Robin D. G. Cooper
Corporate Officer/Principal chez American Chemical Society
Profil
Robin D.
G.
Cooper is currently a member of the American Chemical Society.
He formerly worked as a Director at PanTherix Ltd.
and as a Senior Vice President-Pharmaceutical Sciences at Rigel Pharmaceuticals, Inc. He received an undergraduate degree from Imperial College London and a doctorate from the University of London.
Postes actifs de Robin D. G. Cooper
| Sociétés | Poste | Début |
|---|---|---|
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
Anciens postes connus de Robin D. G. Cooper
| Sociétés | Poste | Fin |
|---|---|---|
PanTherix Ltd.
 PanTherix Ltd. Pharmaceuticals: GenericHealth Technology PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom. | Directeur/Membre du Conseil | - |
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Robin D. G. Cooper
| Imperial College London | Undergraduate Degree |
| University of London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
PanTherix Ltd.
PanTherix Ltd. Pharmaceuticals: GenericHealth Technology PanTherix Ltd. is a privately held anti-infectives company using structure-based drug design to discover and develop new antibiotics acting on novel targets. The company integrates structural and functional information obtained by protein crystallography and enzymology to accelerate the gene to drug process. The company was founded in 1997 and is headquartered in Glasgow, the United Kingdom. | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Commercial Services |